Optimizing surgical outcomes in papillary thyroid carcinoma with Hashimoto’s Thyroiditis: a retrospective comparative study of unilateral and total thyroidectomy

被引:0
|
作者
Xiaoyong Wen [1 ]
Shiwei Zhou [2 ]
Wu Li [1 ]
Hui Li [1 ]
Xiaohua Song [1 ]
Yu Mao [1 ]
Zeyu Li [1 ]
Guangji Chen [2 ]
Xiaowei Peng [1 ]
Peng Wu [2 ]
机构
[1] Central South University/Hunan Cancer Hospital,Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine
[2] Central South University,Department of Thyroid Surgery, the Second Xiangya Hospital
[3] University hospital,Department of Thyroid Surgery
[4] Central South University,undefined
[5] The Affiliated Cancer Hospital of Xiangya School of Medicine,undefined
[6] Central South University/Hunan Cancer Hospital,undefined
关键词
Papillary thyroid carcinoma; Hashimoto’s thyroiditis; Unilateral thyroidectomy; Total thyroidectomy; Preoperative thyroid peroxidase antibody; Fatigue; Quality of life;
D O I
10.1038/s41598-024-82626-x
中图分类号
学科分类号
摘要
The management of papillary thyroid carcinoma (PTC) concurrent with Hashimoto’s thyroiditis (HT) lacks standardized guidelines, especially concerning surgical strategies. This study aimed to compare unilateral thyroidectomy (UT) with total thyroidectomy (TT) in PTC-HT patients to optimize clinical management and improve postoperative outcomes. This retrospective study included PTC-HT patients undergoing thyroid surgery at a tertiary academic medical institution from January 2018 to August 2023. The patients were grouped according to the quartiles of preoperative thyroid peroxidase antibody (TPOAB) levels at the last follow-up. Additionally, patients were divided into UT and TT groups, with propensity score matching (PSM) to ensure comparability. Patients were also stratified by TPOAB levels (L: 100–400, M: 400–1000, H: >1000). Patient-reported outcomes (PROMs), including quality of life and fatigue, were compared between UT and TT groups within each TPOAB subgroup (ΔPROMs = UT-TT). 246 patients were included. Those with higher TPOAB levels at the last follow-up reported increased physical fatigue scores. After PSM, there were no significant demographic differences between UT and TT groups. During a median follow-up of 16 months for UT and 20 months for TT, no recurrence or metastasis occurred. Compared to the UT group, the TT group exhibited lower TPOAB levels at the last follow-up (65.7 ± 78 vs. 374.6 ± 331.9, p < 0.001), and lower physical fatigue scores (3.6 ± 2.5 vs. 4.5 ± 2.8, p = 0.039). However, TT was associated with a higher incidence of transient hypoparathyroidism (7.8% vs. 1.1%, p = 0.030). Stratified analysis by preoperative TPOAB levels revealed significant differences in ΔPROMs (Physical fatigue) between L and H groups (0.2 ± 3.5 vs. 4.6 ± 2, p = 0.004) and between M and H groups (0.6 ± 4.5 vs. 4.6 ± 2, p = 0.037). ΔPROMs (Mental fatigue) also significantly differed between L and H groups (0 ± 1.8 vs. 1.6 ± 0.9, p = 0.026). For PTC-HT patients, particularly those with high preoperative TPOAB levels, TT offers advantages in alleviating fatigue symptoms but carries a higher risk of complications. Therefore, clinical decision-making should consider patient-specific factors, particularly preoperative TPOAB levels, to determine the optimal surgical approach.
引用
收藏
相关论文
共 50 条
  • [41] Outstanding Combination of Primary Thyroid Lymphoma, Papillary Carcinoma, and Hashimoto's Thyroiditis
    Bolanos, Francina
    Pena Gomezportugal, Emmanuel
    Guzman del Alba, Enrique
    Santillan Doherty, Patricio
    Juarez, Fortunato
    CHEST, 2014, 145 (03)
  • [42] The distinct expression of molecular markers in Hashimoto's thyroiditis and papillary carcinoma of thyroid
    Lee, J. H.
    Kim, C. H.
    Won, N. H.
    Choi, J. S.
    Yeom, B. W.
    Chae, Y. S.
    LABORATORY INVESTIGATION, 2007, 87 : 225A - 226A
  • [43] Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto’s thyroiditis
    Lirong Wang
    Jiawen Chen
    Xin Yuan
    Juan Wang
    Lei Sun
    Jue Jiang
    Lin Zhang
    Min Liu
    Qi Zhou
    BMC Endocrine Disorders, 22
  • [44] Relationship between Hashimoto's thyroiditis and papillary thyroid carcinoma in children and adolescents
    Zeng, R.
    Zhao, M.
    Niu, H.
    Yang, K. X.
    Shou, T.
    Zhang, G-Q
    Yan, X-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) : 7778 - 7787
  • [45] A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk
    Lai, Xingjian
    Xia, Yu
    Zhang, Bo
    Li, Jianchu
    Jiang, Yuxin
    ONCOTARGET, 2017, 8 (37) : 62414 - 62424
  • [46] Epitope specific immunity in Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?
    Ehlers, M.
    Papewalis, C.
    Bernecker, C.
    Haase, M.
    Allelein, S.
    Schinner, S.
    Willenberg, H. S.
    Hautzel, H.
    Feldkamp, J.
    Schott, M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [47] The distinct expression of molecular markers in Hashimoto's thyroiditis and papillary carcinoma of thyroid
    Lee, J. H.
    Kim, C. H.
    Won, N. H.
    Choi, J. S.
    Yeom, B. W.
    Chae, Y. S.
    MODERN PATHOLOGY, 2007, 20 : 225A - 226A
  • [48] Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis
    Wang, Lirong
    Chen, Jiawen
    Yuan, Xin
    Wang, Juan
    Sun, Lei
    Jiang, Jue
    Zhang, Lin
    Liu, Min
    Zhou, Qi
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [49] SURGICAL MANAGEMENT OF PAPILLARY CARCINOMA OF THE THYROID GLAND - THE CASE FOR TOTAL THYROIDECTOMY
    MACDONALD, I
    KOTIN, P
    ANNALS OF SURGERY, 1953, 137 (02) : 156 - 164
  • [50] Comparison of Outcomes Following Thyroid Isthmusectomy, Unilateral Thyroid Lobectomy, and Total Thyroidectomy in Patients with Papillary Thyroid Microcarcinoma of the Thyroid Isthmus: A Retrospective Study at a Single Center
    Gui, Zhiqiang
    Wang, Zhihong
    Xiang, Jingzhe
    Sun, Wei
    He, Liang
    Dong, Wenwu
    Huang, Jiapeng
    Zhang, Dalin
    Lv, Chengzhou
    Qin, Yuan
    Zhang, Ting
    Shao, Liang
    Zhang, Ping
    Zhang, Hao
    MEDICAL SCIENCE MONITOR, 2020, 26